Ashuach, Tal https://orcid.org/0000-0003-1939-0865
Gabitto, Mariano I. https://orcid.org/0000-0001-6911-344X
Koodli, Rohan V.
Saldi, Giuseppe-Antonio https://orcid.org/0000-0002-9994-7354
Jordan, Michael I. https://orcid.org/0000-0001-8935-817X
Yosef, Nir https://orcid.org/0000-0001-9004-1225
Article History
Received: 15 November 2021
Accepted: 10 May 2023
First Online: 29 June 2023
Competing interests
: N.Y. is an adviser and/or has equity in Cellarity, Celsius Therapeutics and Rheos Medicines. T.A is an employee of Vevo Therapeutics. All other authors declare no competing interests.